BRESSANIN, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 1.032
EU - Europa 645
AS - Asia 341
AF - Africa 30
SA - Sud America 4
OC - Oceania 1
Totale 2.053
Nazione #
US - Stati Uniti d'America 1.028
GB - Regno Unito 151
CN - Cina 146
IT - Italia 128
SE - Svezia 114
DE - Germania 83
SG - Singapore 79
VN - Vietnam 61
FR - Francia 35
IE - Irlanda 34
IN - India 27
UA - Ucraina 27
RU - Federazione Russa 24
BG - Bulgaria 18
JO - Giordania 18
ZA - Sudafrica 15
EE - Estonia 9
TG - Togo 9
BE - Belgio 6
CH - Svizzera 5
CA - Canada 4
FI - Finlandia 4
LB - Libano 4
CI - Costa d'Avorio 3
IR - Iran 3
BR - Brasile 2
CL - Cile 2
ID - Indonesia 2
NG - Nigeria 2
NL - Olanda 2
PT - Portogallo 2
AU - Australia 1
ES - Italia 1
GR - Grecia 1
HR - Croazia 1
MU - Mauritius 1
PH - Filippine 1
Totale 2.053
Città #
Fairfield 134
Southend 133
Ashburn 90
Chandler 83
Woodbridge 72
Singapore 71
Santa Clara 66
Houston 64
Bologna 61
Seattle 60
Wilmington 53
Cambridge 45
Princeton 45
Ann Arbor 41
Dong Ket 34
Dublin 34
Boardman 24
Jacksonville 19
Nanjing 19
Amman 18
Sofia 18
Padova 16
Westminster 16
Beijing 13
San Diego 11
Berlin 10
Changsha 10
Mülheim 10
Lomé 9
Saint Petersburg 9
Los Angeles 8
New York 8
Shenyang 8
Turin 8
Washington 8
Milan 7
Bremen 6
Brussels 6
Guangzhou 6
Jinan 6
Nanchang 5
Tianjin 5
Bern 4
Hebei 4
Helsinki 4
Jiaxing 4
Kunming 4
Redwood City 4
Abidjan 3
Andover 3
Casorezzo 3
Fremont 3
Norwalk 3
Riccione 3
San Venanzo 3
Shanghai 3
Taizhou 3
Zhengzhou 3
Abeokuta 2
Bühl 2
Changchun 2
Forlì 2
Haikou 2
Hangzhou 2
Hefei 2
Jakarta 2
Langfang 2
Lanzhou 2
London 2
Medford 2
Memphis 2
Montreal 2
Moscow 2
Ningbo 2
Redmond 2
Zanjan 2
Alexandria 1
Amsterdam 1
Augusta 1
Baotou 1
Brescia 1
Casina 1
Chengdu 1
Chongqing 1
Costa Mesa 1
Dallas 1
Dearborn 1
Des Moines 1
Falls Church 1
Ferrara di Monte Baldo 1
Florence 1
Frankfurt Am Main 1
Fuzhou 1
Groningen 1
Hamburg 1
Handan 1
Harbin 1
Jieyang 1
Jinhua 1
Kiev 1
Totale 1.483
Nome #
Activity of the Selective IκB kinase Inhibitor BMS-345541 against T-Cell Acute Lymphoblastic Leukemia: involvement of FOXO3a 156
A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia. 148
Proteolysis of the proofreading subunit controls the assembly of Escherichia coli DNA polymerase III catalytic core. 133
Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells. 131
Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia. 123
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. 116
Nuclear phosphoinositides and their roles in cell biology and disease. 115
Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies 114
MYCN is a novel oncogenic target in pediatric T-cell Acute Lymphoblastic Leukemia 114
Spermidine application to young developing peach fruits leads to a slowing down of ripening by impairing ripening-related ethylene and auxin metabolism and signaling 111
Therapeutic targeting of polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblstic leukemia. 111
The emerging multiple roles of nuclear Akt. 109
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia 106
Towards a precision medicine approach and in situ vaccination against prostate cancer by psma-retargeted ohsv 105
Stabilization of the Escherichia coli DNA polymerase III epsilon subunit by the theta subunit favors in vivo assembly of the Pol III catalytic core 98
Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. 87
Genotype of Immunologically Hot or Cold Tumors Determines the Antitumor Immune Response and Efficacy by Fully Virulent Retargeted oHSV 87
Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels. 83
Efficacy of Systemically Administered Retargeted Oncolytic Herpes Simplex Viruses—Clearance and Biodistribution in Naïve and HSV-Preimmune Mice 57
Totale 2.104
Categoria #
all - tutte 5.725
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.725


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020340 0 0 0 0 0 58 64 61 75 33 8 41
2020/2021186 41 28 6 6 1 10 3 16 17 6 12 40
2021/2022449 60 5 32 30 21 25 10 30 15 62 98 61
2022/2023393 43 39 15 54 26 33 12 17 84 11 34 25
2023/2024154 6 14 26 21 19 35 9 14 3 3 3 1
2024/2025247 16 48 29 28 100 26 0 0 0 0 0 0
Totale 2.104